BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3302890)

  • 1. Advances in the correction of immunodeficiency by bone marrow transplantation.
    Buckley RH
    Pediatr Ann; 1987 May; 16(5):412-3, 416-21. PubMed ID: 3302890
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunorestoration.
    Good RA; Kapoor N
    Symp Fundam Cancer Res; 1986; 38():269-74. PubMed ID: 3529277
    [No Abstract]   [Full Text] [Related]  

  • 4. Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion.
    Niethammer D; Goldmann SF; Flad HD; Bienzle U; Dieterle U; Haas RJ; Heymer B; Meigel W; Belohradsky BH; Kleihauer E
    Clin Immunol Immunopathol; 1981 Mar; 18(3):387-401. PubMed ID: 7018767
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.
    Reinherz EL; Geha R; Rappeport JM; Wilson M; Penta AC; Hussey RE; Fitzgerald KA; Daley JF; Levine H; Rosen FS; Schlossman SF
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6047-51. PubMed ID: 6764536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic reconstititution of a patient with combined immunodeficiency disease.
    Biggar WD; Good RA; Park BH
    J Pediatr; 1972 Aug; 81(2):301-6. PubMed ID: 4402890
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological dysregulation after bone-marrow transplantation in patients with severe combined immunodeficiency.
    Virelizier JL; Durandy A; Ballet JJ; Griscelli C
    Pathol Biol (Paris); 1978 Jan; 26(1):21-2. PubMed ID: 29268
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation.
    Bortin MM; Rimm AA
    JAMA; 1977 Aug; 238(7):591-600. PubMed ID: 18618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
    O'Reilly RJ; Keever C; Kernan NA; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):55-60. PubMed ID: 3321647
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Bone marrow transplantation.
    Can Med Assoc J; 1975 Feb; 112(3):270. PubMed ID: 234027
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency.
    Keever CA; Flomenberg N; Brochstein J; Sullivan M; Collins NH; Burns J; Dupont B; O'Reilly RJ
    Clin Immunol Immunopathol; 1988 Sep; 48(3):261-76. PubMed ID: 3042210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of immunologic function in a patient with severe combined immunodeficiency following transplantation of marrow from an HLA-A,B,C nonidentical but MLC-compatible paternal donor.
    O'Reilly RJ; Kapoor N; Pollack M; Sorell M; Chaganti RS; Blaese RM; Wank R; Good RA; Dupont B
    Transplant Proc; 1979 Dec; 11(4):1934-7. PubMed ID: 43615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bone marrow transplantation and immunologic reconstitution].
    Piazzon I; Dosne Pasqualini C
    Medicina (B Aires); 1981; 41(2):233-43. PubMed ID: 7024717
    [No Abstract]   [Full Text] [Related]  

  • 16. Histoincompatible bone marrow transplants in humans.
    Clift RA; Storb R
    Annu Rev Immunol; 1987; 5():43-64. PubMed ID: 3297107
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of hematopoietic cells for lethal congenital immunodeficiencies.
    O'Reilly RJ; Kapoor N; Kirkpatrick D; Flomenberg N; Pollack MS; Dupont B; Good RA; Reisner Y
    Birth Defects Orig Artic Ser; 1983; 19(3):129-37. PubMed ID: 6140037
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined immunodeficiency and thymic abnormalities.
    Webster AD
    J Clin Pathol Suppl (R Coll Pathol); 1979; 13():10-4. PubMed ID: 42651
    [No Abstract]   [Full Text] [Related]  

  • 20. A variant of severe combined immunodeficiency with normal in vitro response to allogeneic cells and an increase in circulating B lymphocytes persisting several months after successful bone marrow graft.
    Seligmann M; Griscelli C; Preud'homme JL; Sasportes M; Herzog C; Brouet JC
    Clin Exp Immunol; 1974 Jun; 17(2):245-52. PubMed ID: 4282850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.